Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
about
A clinical review of the treatment of catatoniaNeuroinflammation and psychiatric illness'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIIIAutoimmune dementia: clinical course and predictors of immunotherapy responseClinical experience and laboratory investigations in patients with anti-NMDAR encephalitisCellular and synaptic mechanisms of anti-NMDA receptor encephalitisThe frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis ProjectTreatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyAnti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescentsAntibody-associated epilepsies: Clinical features, evidence for immunotherapies and future research questionsDetection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous SystemThe Historical Development of Immunoendocrine Concepts of Psychiatric Disorders and Their TherapyAutoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCCLimbic Encephalitis: Potential Impact of Adaptive Autoimmune Inflammation on Neuronal Circuits of the AmygdalaMolecular Pathogenesis of Anti-NMDAR EncephalitisAnti-NMDA-receptor encephalitis presenting with catatonia and neuroleptic malignant syndrome in patients with intellectual disability and autismAnti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatmentClinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directionsAutoimmune encephalitis updateDiagnosis and management of paraneoplastic neurologic disordersThe neuroimmunology of schizophreniaGlutamatergic autoencephalitides: an emerging fieldCell-surface central nervous system autoantibodies: clinical relevance and emerging paradigmsAutoimmune encephalitis in childrenNeuroimaging of frontal-limbic dysfunction in schizophrenia and epilepsy-related psychosis: toward a convergent neurobiologyNMDA receptor encephalitis causing reversible caudate changes on MRI and PET imagingGRIN2A: an aptly named gene for speech dysfunctionAnti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitisNeuronal central nervous system syndromes probably mediated by autoantibodiesMapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous systemProgress in autoimmune epileptic encephalitisAnti-N-methyl-D-aspartate receptor encephalitis with occult ovarian teratoma: a case reportAutoimmune encephalitis in psychiatric institutions: current perspectivesSeizures and Epilepsies due to Channelopathies and Neurotransmitter Receptor Dysfunction: A Parallel between Genetic and Immune AspectsNeuroinflammation: Ways in Which the Immune System Affects the BrainAntibody-Mediated Autoimmune Encephalopathies and ImmunotherapiesRecognizing Autoimmune-Mediated Encephalitis in the Differential Diagnosis of Limbic DisordersThe use of cerebrospinal fluid and neuropathologic studies in neuropsychiatry practice and researchDisease-relevant autoantibodies in first episode schizophrenia
P2860
Q21129101-30DD46C5-3E11-4F14-A203-06A59844329EQ21245244-1EB4631F-4752-488B-B34F-743B6A66CC26Q22000623-0C909939-3324-4BD0-94A0-88B913049FA2Q24597504-1CE5E3D7-97BB-4E21-B78F-547BE8157EE4Q24614608-F4B37EF5-B925-403B-B3AC-6ACA1B0D5EEAQ24620536-93281CE1-23A8-4AF0-9651-3DB2A763A1A0Q24621267-B8C7A1DF-6D39-4E97-88BD-0D2B1C98C799Q24627766-04800421-7B2F-41F2-8295-7041F3F586C5Q24644532-C68CFEB9-4F63-436B-A734-8BD02A168175Q26741919-ADD347E9-DA94-4511-8422-93D28ACC929AQ26746048-DE42A0FC-AA52-4214-BB98-EBEC6D31EE99Q26774472-B4F081A6-514E-4B4B-8ED3-2C039EB82443Q26775915-AD3C85C5-4F53-4DE9-83E4-683F4E08FBB7Q26786113-B36C98E9-3CCB-481B-99DB-5D08A71AC202Q26797363-6CC230F3-5D20-4C6B-AAE2-7B191094FA1FQ26801883-535816B3-021E-4067-9C16-4EBBC57AFA25Q26801893-A9507691-2A48-4054-9437-E9F5E25A9882Q26801897-51B62D97-45D3-4540-8852-919923AB8C75Q26824216-97009050-DDA9-4914-A641-113AD51FC94CQ26827114-AA21C242-EF65-4266-BD26-57A3F8CE3CEEQ26853598-21BC95CF-593E-4D81-94F6-80B5345CC650Q26859392-1732CEF3-3C0B-4637-974F-8E4878CE7B21Q26992294-A111969B-33F2-4F2D-870A-02F297DAC370Q27006941-D77BDA17-44E0-40B5-A307-C504096CB0C7Q27010170-7C12124D-71D7-4D75-93D3-FA7B0C22D69DQ27015812-77149DC3-3034-42E5-8CD9-F712061DA6E4Q27312744-9FA2C8DA-FC0D-4F36-9DF6-1E168F0F4C7EQ27349343-A4DE3EC3-50B6-4515-B37A-CD4DF5EA3E73Q27490347-8C586F4B-6AF4-4DAB-B74B-AB9FD557FC1AQ28072253-7885534F-675C-49B0-9FCE-10CC497B439CQ28075974-2AB65A7F-274A-470E-8CBF-D4D8F85F92E0Q28077159-BA7CAFFC-3A6E-4DF1-9AE0-C216915981B8Q28079503-0F360F3F-BE50-4AD7-A225-369FD8BB3B72Q28079666-5C6A8995-9B70-485B-A84C-2727F1F07709Q28079865-32A1988A-BE08-4CA2-8C28-0B9BBBBCA6DDQ28080620-535E7BF4-A7D2-4FA6-AC9E-1008A809DC61Q28084055-1A76586E-BCD2-49E7-99C7-B1EB1399550BQ28087810-0028DD6D-5F5B-447C-A9F9-D9B0459B0A27Q28088291-A2989DA8-3E4F-43FE-A5C4-ACD1BF283360Q28296584-783C6CE2-645C-445E-919B-4B66261E9038
P2860
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
@ast
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
@en
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
@nl
type
label
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
@ast
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
@en
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
@nl
prefLabel
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
@ast
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
@en
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
@nl
P2093
P2860
P50
P3181
P1433
P1476
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
@en
P2093
Amy J Gleichman
David R Lynch
Jeffrey E Rossi
Meizan Lai
Rita Balice-Gordon
Scott K Dessain
Xiaoyu Peng
P2860
P304
P3181
P356
10.1016/S1474-4422(08)70224-2
P407
P577
2008-10-11T00:00:00Z